Sign in to baba News

The Desk, the news read to you every hour, is part of News Plus.

or use an email code

By continuing you agree to the terms and privacy policy.

Keep the whole picture

News Plus opens the cross-newsroom layer: who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • Every newsroom clip, from every platform
  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome, one more step

News Plus opens the cross-newsroom layer: who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • Every newsroom clip, from every platform
  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

By continuing you agree to the terms and privacy policy.

Health · Full coverage

Pharma Giants Spar Over Weight-Loss Drugs at Diabetes Conference

How 1 Israeli newsrooms (in English, Hebrew) covered this story — translated into English and compared side by side.

100% center
Center 2

By Oren Rice

What happened

Pharmaceutical giants Novo Nordisk and Eli Lilly presented competing studies at a diabetes conference, each claiming their weight-loss drugs were superior in efficacy and safety. While Eli Lilly's Mounjaro showed greater weight loss in direct trials, Novo Nordisk highlighted Ozempic's potential cardiovascular benefits, though definitive comparisons remain pending.

  • 01Novo Nordisk and Eli Lilly presented conflicting data on weight-loss drugs at a diabetes conference.
  • 02Eli Lilly's Mounjaro showed greater weight loss than Novo Nordisk's Wegovy in direct trials.
  • 03Novo Nordisk claimed Ozempic offered better heart protection for diabetic patients.
  • 04Direct comparative trials for cardiovascular protection between the leading drugs are still lacking.
  • 05Weight-loss injections are not state-funded for adults in Israel and pills are often unaffordable.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

By continuing you agree to the terms and privacy policy.

Keep the whole picture

News Plus opens the cross-newsroom layer: who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • Every newsroom clip, from every platform
  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

The coverage

One newsroom on this story

Mentioned
People
OrganizationsNovo Nordisk, Eli Lilly, European Association for the Study of Diabetes, Mass General Brigham, Harvard
PlacesMilan, Italy, United States, Germany

Full coverage · 2 outlets

The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.

YnetnewsCenter · English1 day ago
Pharma Giants Spar Over Weight-Loss Drugs at Diabetes Conference
YnetCenter · Hebrew1 day ago
Drug Giants Clash Over Weight Loss and Heart Health Drugs